Business Advisors

Paige Arnof-Fenn Founder and CEO of Mavens and Moguls, a global marketing strategy firm, Board Chair of the Alumni Board of Stanford University, Chair of the Board of Trustees of the Sports Museum at the Boston Garden.

Janice Bourque Managing Director of Life Sciences for Hercules Technology Growth Capital. Formerly President/CEO of the Massachusetts Biotechnology Council (MBC) for 12 years and Senior Vice President and Group Head-Life Sciences at Comerica Bank.

John L. Brooks, III President and CEO of Arete Worldwide LLC, Chairman of the Board of Directors of Cellnovo, Previously President and CEO of the Joslin Diabetes Center.

Stephen Korn Former Vice-President, General Counsel and Secretary of Zoll Medical Corp., Ionics, Inc., and Symbolics.

Daniel Kuzmak General Manager of Atlas High Purity Solutions Division of Quench USA a subsidiary of AquaVentures Holdings LLC. Previously CFO of Coaltek, Ionics, Terex and ABB.

James Mulvihill, DMD Former CEO: University of Connecticut Health Center, Juvenile Diabetes Foundation International, Forsyth Institute; former Chairman, Travelers Health Company, former Consultant to the Robert Wood Johnson Foundation.

Paul Sabin
Principal at Fikst, a design and development firm, numerous awards and patents.

Scientific Advisors

William Carson
Co-founder and Senor Vice President Spectra-Analysis, Inc. Former Vice President of Research and Development groups at Ionics, PerSeptive Biosystems, Millipore and Waters Associates.Over $1 billion of sales of products resulted from 21 issued US and more than 75 corresponding foreign patents.

Kenneth Kustin, PhD
Emeritus Professor of Chemistry at Brandeis University, formerly Chair of the Department.  He received a B. Sc. degree in Chemistry and Mathematics at Queens College, a Ph. D. degree from the University of Minnesota in Inorganic Chemistry, and he was a postdoctoral fellow in the laboratory of Nobel-prize recipient Manfred Eigen at the Max Planck Institute for Physical Chemistry in Germany.

Eric S. Rosenberg, MD
Associate Professor of Medicine, Harvard School of Medicine, Associate Director, Clinical Microbiology, Infectious Diseases Division, Massachusetts General Hospital, numerous publications, presentations and awards. His main area of research has been primarily funded by grants from the National Institutes of health (NIH).

George J. Vella, PhD
PhD in BioOrganic Chemistry, senior executive positions strategic planning, research, development and operations with Waters Associates, Millipore, PerSeptive Biosystems, Applied Biosystems, Charley’s Fund; Principal Investigator Cardiovascular Research, Hospital for Sick Children. American Association for the Advancement of Science, Review Board for cell biology,  NIH Special Emphasis Program.

 

Back to management

home  |   applications  |   product info  |   management   |   about (ClO2)   |   news & info   |   investors   |   contact